INVENT Adults (18-64 years) Elderly (≥65 years) Immunocompromised patients Hospital SARS-CoV-2 Respiratory syncytial virus Influenza virus Adenovirus Rhinovirus Human metapneumovirus Parainfluenza Virus Pharmacological intervention Antivirals SNG001